Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma

Clin Interv Aging. 2013:8:1467-70. doi: 10.2147/CIA.S47350. Epub 2013 Oct 31.

Abstract

Glaucoma is a common eye disease in the aged population and has severe consequences. The present study examined the therapeutic effects of bone marrow mesenchymal stem cell (BMSC) transplantation in preventing loss of visual function in aged rats with glaucoma caused by laser-induced ocular hypertension. We found that BMSCs promoted survival of retinal ganglion cells in the transplanted eye as compared with the control eye. Further, in swimming tests guided by visual cues, the rats with a BMSC transplant performed significantly better. We believe that BMSC transplantation therapy is effective in treating aged rats with glaucoma.

Keywords: aging; cell therapy; glaucoma; stem cell; transplantation.

MeSH terms

  • Animals
  • Blindness / prevention & control*
  • Cell Count / methods
  • China
  • Glaucoma / surgery*
  • Intraocular Pressure
  • Male
  • Mesenchymal Stem Cell Transplantation*
  • Models, Animal
  • Rats
  • Rats, Sprague-Dawley
  • Retinal Ganglion Cells*
  • Treatment Outcome